Inhibition of the EGFR and Hedgehog Signaling Pathways Demonstrate Potent Growth Inhibition in an Animal Model of Esophageal Carcinogenesis
G. Sui,P. Bonde,S. Dhara,G. Marti,M. Freguson,J. Wang,E. Jaffee,M. Duncan,E. Montgomery,A. Maitra,J. Harmon
DOI: https://doi.org/10.1016/j.jss.2004.07.040
2004-01-01
Abstract:Introduction. Advancements in experimental therapeutics for esophageal cancers have been hampered by the lack of a reliable preclinical model that recapitulates the biology of human cancer, including in vivo growth and metastases. Methods. Bilious reflux was induced by esophago-jejunostomy in Sprague-Dawley rats. Eight of nine SD rats developed squamous or adenosquamous cancers, and three new cell lines were created by in vitro propagation, JA and JB lines from one, and AMY line from the other. We subsequently tested the ability of these cell lines to propagate long-term in vitro and form tumors in vivo. In addition, we determined the effects of small molecule inhibitors of two important oncogenic pathways---the epidermal growth factor receptor (EGFR) and hedgehog (Hh) signaling pathways, in vitro. Relative growth inhibition was measured as described (Berman et al Nature 2003) at 48 and 96 h, using standard MTS assay. Results. JA, JB, and AMY cell lines are able to grow continuously in vitro, with consistent in vivo growth in athymic mice, both as subcutaneous xenografts and as orthotopically implanted tumors at the gastroesophageal serosa (N = 2 mice per line, six of six engrafted each). By histology, the tumors grow in vivo as a well-differentiated keratinizing squamous cell carcinomas. Iressa (gefitinib), an EGFR inhibitor (5 μm), caused significant growth inhibition in all three cell lines (JA > JB > AMY) compared to mock-treated cells, mirrored functionally by down regulation of activated targets of the EGFR pathway, phospho-ERK1/2, and phospho-MEK levels, in the EGFR-inhibited cells. Cyclopamine, an Hh pathway antagonist (dose 6 μm), caused significant growth inhibition in the AMY cell line, but not JA or JB lines; growth inhibition was accompanied by significant down regulation of Hh reporter activity at 24 h in the AMY cells but not JA or JB lines, consistent with specific antagonism of the Hh signaling pathway. Conclusions. We have established a model of esophageal carcinogenesis, with ability for long-term in vitro and in vivo passage and exhibiting pathway-specific antagonistic effects.